The stock of MAIA Biotechnology Inc (AMEX: MAIA) has decreased by -9.52 when compared to last closing price of 3.36.Despite this, the company has seen a gain of 4.11% in its stock price over the last five trading days. Business Wire reported 2024-04-05 that CHICAGO–(BUSINESS WIRE)–MAIA Biotechnology to Present at Two Investor Conferences in April 2024.
Is It Worth Investing in MAIA Biotechnology Inc (AMEX: MAIA) Right Now?
The 36-month beta value for MAIA is at 0.12. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for MAIA is 16.03M, and currently, shorts hold a 4.90% of that float. The average trading volume for MAIA on May 09, 2024 was 366.09K shares.
MAIA’s Market Performance
The stock of MAIA Biotechnology Inc (MAIA) has seen a 4.11% increase in the past week, with a 18.29% rise in the past month, and a 114.08% gain in the past quarter. The volatility ratio for the week is 7.32%, and the volatility levels for the past 30 days are at 11.27% for MAIA.. The simple moving average for the past 20 days is 15.86% for MAIA’s stock, with a 70.90% simple moving average for the past 200 days.
MAIA Trading at 42.03% from the 50-Day Moving Average
After a stumble in the market that brought MAIA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -15.32% of loss for the given period.
Volatility was left at 11.27%, however, over the last 30 days, the volatility rate increased by 7.32%, as shares surge +23.58% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +123.53% upper at present.
During the last 5 trading sessions, MAIA rose by +4.11%, which changed the moving average for the period of 200-days by +34.51% in comparison to the 20-day moving average, which settled at $2.65. In addition, MAIA Biotechnology Inc saw 159.83% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at MAIA starting from Smith Stan, who purchase 147,492 shares at the price of $2.03 back on Apr 25 ’24. After this action, Smith Stan now owns 1,005,060 shares of MAIA Biotechnology Inc, valued at $299,409 using the latest closing price.
Louie Ngar Yee, the Director of MAIA Biotechnology Inc, purchase 19,665 shares at $2.03 during a trade that took place back on Apr 25 ’24, which means that Louie Ngar Yee is holding 1,167,189 shares at $39,920 based on the most recent closing price.
Stock Fundamentals for MAIA
The total capital return value is set at -6.7. Equity return is now at value -440.12, with -201.88 for asset returns.
Currently, EBITDA for the company is -15.86 million with net debt to EBITDA at 0.32. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.53.
Conclusion
In conclusion, MAIA Biotechnology Inc (MAIA) has had a better performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
